Astellas Pharma Inc.

Japan


 
Total IP 1,112
Total IP incl. subs 1,487 (+ 378 for subs)
Total IP Rank # 1,198
IP Activity Score 3.4/5.0    543
IP Activity Rank # 1,327
IP AS incl. subs 3.2/5.0    786
Stock Symbol
ISIN JP3942400007
Market Cap. 3705887172787.5  (JPY)
Industry Drug Manufacturers—General
Sector Healthcare
Dominant Nice Class Pharmaceutical, veterinary and s...

Patents

Trademarks

247 83
115 47
469 99
52
 
Last Patent 2025 - Fc region variant
First Patent 1977 - Syn-isomer of 3,7-disubstituted-...
Last Trademark 2025 - YOUR HEART IN GOOD HANDS
First Trademark 1979 - JOSACINE

Subsidiaries

12 subsidiaries with IP (183 patents, 195 trademarks)

6 subsidiaries without IP

 Register for free to unlock the subsidiary list

Industry (Nice Classification)

Latest Inventions, Goods, Services

2025 G/S Computer application software for use with web-based platforms and mobile devices in the nature o...
G/S Downloadable computer application software for use with web-based platforms and mobile devices in...
2024 Invention Formulations of enzalutamide. This disclosure provides formulations of enzalutamide and their us...
G/S Pharmaceutical preparations for intraoperative ureter and lymph node visualization for use during...
Invention Antibody-drug complex containing toll-like receptor 7/8 dual agonist compound. An antibody-drug ...
Invention Fc region variant. According to one embodiment, provided is a sialylated Fc region variant compri...
Invention Idez variant. According to one embodiment of the present invention, provided is an IdeZ variant h...
Invention Modified bacteriophage. The present invention provides a bacteriophage having bacteriolytic activ...
Invention Pharmaceutical composition containing tagged site-antihuman antibody fab fragment complex. Provi...
Invention Combination therapy involving antibodies against claudin 18.2 for treatment of cancer. The prese...
Invention Pharmaceutical composition comprising a pan-kras degrader. There is provided herein a compound of...
Invention Pharmaceutical composition comprising a quinazoline compound. There is provided herein compounds ...
Invention Cell penetrating peptide. An object of the present invention is to provide a cell penetrating pe...
Invention Method for producing type 2 innate lymphocytes. The present invention addresses the problem of es...
Invention Antibodies against claudin 18.2 useful in cancer diagnosis. The invention relates to antibodies ...
Invention Pharmaceutical composition for modified release. A pharmaceutical composition for modified releas...
G/S Providing medical information
Invention Terminal apparatus, game execution method, program, and server. This terminal apparatus is for ex...
Invention Cell sowing method. The present invention relates to a cell sowing method and a cell culture meth...
G/S incubation services, namely, rental of office space to freelancers and start-ups Rental of labora...
G/S Provision of incubation services, namely, arranging of business resources and/or finance for busi...
Invention Carbamoyl lipid or urea lipid each having cyclic amine, lipid nanoparticles containing same, and ...
Invention Antibodies useful in cancer diagnosis. The invention relates to antibodies directed against an e...
2023 Invention Engineered natural killer cells and related methods. The disclosure provides a population of engi...
Invention 4-aminopiperidine compound, lipid nanoparticles thereof, and pharmaceutical composition containin...
Invention Anti-tspan8/anti-cd3 bispecific antibody and anti-tspan8 antibody. An objective of the present i...
Invention Combination of talazoparib and enzalutamide in the treatment of metastatic castration-resistant p...
G/S Pharmaceutical product for the treatment of cancer.
G/S Pharmaceutical product for the treatment of cancer.
G/S Pharmaceutical product for the treatment of cancer
Invention Antibody-drug complex containing toll-like receptor 7/8 dual agonist compound. The present invent...
Invention Fused pyridazine derivative. The present invention addresses the problem of providing a pharmaceu...
Invention Composition for near infrared lymphatic imaging and uses and dosages therefor. Disclosed are imag...
Invention Use of anti-cldn4-anti-cd137 bispecific antibody combined with pd-1 signal inhibitor for cancer t...
G/S provision of incubation services, namely, arranging of business resources and/or finance for busi...
G/S Incubation services, namely, rental of office space to freelancers and start-ups Rental of labora...
G/S Business administration of health reimbursement arrangements; providing business information rega...
Invention Bispecific trivalent antibodies binding to claudin6 or claudin18.2 and cd3 for treatment of claud...
Invention Monoclonal antibodies against claudin-18 for treatment of cancer. The present invention provides...
G/S Pharmaceutical products for the treatment of cancer.
G/S Pharmaceutical preparations for the treatment of cancer.
G/S Pharmaceutical preparations for the treatment of cancer
G/S Pharmaceutical preparations for the treatment of cancer
G/S Downloadable medical software for processing and displaying images on ultrasound medical imaging ...
G/S Pharmaceutical preparations. Software for medical purposes; computer programs; telecommunication ...
G/S Pharmaceutical preparations for the treatment of type2 diabetes mellitus, metabolic syndrome, bla...
2022 Invention Pharmaceutical composition comprising a quinazoline compound. The present invention has an objec...
Invention Indocyanine compound-containing solid pharmaceutical composition. Provided is a stable solid pha...
Invention Agents for treatment of claudin expressing cancer diseases. The present invention provides bindi...
G/S Pharmaceutical preparation for the treatment of cancer and for gastrointestinal disorders and dis...
G/S Pharmaceutical product for the treatment of cancer and for gastro-intestinal disorders and disea...
G/S Pharmaceutical product for the treatment of cancer and for gastro-intestinal disorders and diseas...
G/S Pharmaceutical preparations for the treatment of cancer and for gastro-intestinal disorders and d...
G/S Pharmaceutical products for the treatment of cancer and for gastro-intestinal disorders and disea...
Invention A pharmaceutical composition for imaging. Intraoperative ureter identification helps reduce the ...
Invention Vascular endothelial growth factor (vegf)-highly expressing pericyte-like cell. An object of the...
Invention Method for producing vascular endothelial growth factor (vegf)- highly expressing pericyte-like c...
Invention Methods of use of ppar agonist compounds and pharmaceutical compositions thereof. The present di...
Invention Machine learning methods to predict menopause symptoms and treatment options. Techniques are pro...
Invention Substituted triazine compound. An object of the present invention is to provide a pharmaceutical...
Invention Anti-cldn4/anti-cd137 bispecific antibody. An object of the present invention is to provide an an...
Invention Composition for contrast imaging of cancer. An object of the present invention is to provide a c...
Invention Electrocardiogram analysis assistance device, program, electrocardiogram analysis assistance meth...
Invention Combination of talazoparib and an anti-androgen for the treatment of ddr gene mutated metastatic ...
Invention Pericyte having basic fibroblast growth factor (bfgf) gene introduced therein. An object of the ...
Invention Methods of reducing risk of prostate cancer progression. This disclosure provides methods of red...
Invention Quinazoline compound for inducing degradation of g12d mutant kras protein. [Problem] To provide ...
Invention 4-aminoquinazoline compound. [Problem] A compound useful as an active ingredient of a pharmaceut...
2021 Invention Arrhythmic state detection assisting device and program. An arrhythmic state detection assisting...
2020 Invention Guide rna for editing polyadenylation signal sequence of target rna. An object of the present in...